Fosun Pharmaceutical’s $135 Million COVID-19 Vaccine Strategic Alliance with Biopharmaceutical New Technologies

Paul Hastings LLP advised Shanghai Fosun Pharmaceutical (Group) Co., Ltd in its alliance with Biopharmaceutical New Technologies of Germany. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SH,...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

KB OREO’s $90 Million Acquisition Of EdgeMarc Energy Pennsylvania Assets And Global Settlement With KeyBank

Davis Polk advised EdgeMarc Energy Holdings, LLC and its affiliates (together, “EdgeMarc”) in the transaction. KB OREO executed the acquisition of EdgeMarc Energy Pennsylvania Assets. In...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here